These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 15952916)

  • 21. Physiological and Metabolic Changes During the Transition from Hyperthyroidism to Euthyroidism in Graves' Disease.
    Chng CL; Lim AY; Tan HC; Kovalik JP; Tham KW; Bee YM; Lim W; Acharyya S; Lai OF; Chong MF; Yen PM
    Thyroid; 2016 Oct; 26(10):1422-1430. PubMed ID: 27465032
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of single daily dose of methimazole and propylthiouracil in the treatment of Graves' hyperthyroidism.
    He CT; Hsieh AT; Pei D; Hung YJ; Wu LY; Yang TC; Lian WC; Huang WS; Kuo SW
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):676-81. PubMed ID: 15163329
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current controversies in the management of Graves' hyperthyroidism.
    Francis N; Francis T; Lazarus JH; Okosieme OE
    Expert Rev Endocrinol Metab; 2020 May; 15(3):159-169. PubMed ID: 32315207
    [No Abstract]   [Full Text] [Related]  

  • 24. Treatment of Graves' hyperthyroidism with thionamides: a position paper on indications and safety in pregnancy.
    Tonacchera M; Chiovato L; Bartalena L; Cavaliere AF; Vitti P
    J Endocrinol Invest; 2020 Feb; 43(2):257-265. PubMed ID: 31784912
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The safety and efficacy of antithyroid drugs.
    Azizi F
    Expert Opin Drug Saf; 2006 Jan; 5(1):107-16. PubMed ID: 16370960
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Elevation of serum creatine kinase during treatment with antithyroid drugs in patients with hyperthyroidism due to Graves disease. A novel side effect of antithyroid drugs.
    Suzuki S; Ichikawa K; Nagai M; Mikoshiba M; Mori J; Kaneko A; Sekine R; Asanuma N; Hara M; Nishii Y; Yamauchi K; Aizawa T; Hashizume K
    Arch Intern Med; 1997 Mar; 157(6):693-6. PubMed ID: 9080924
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Medical treatment of hyperthyroidism: state of the art.
    Fumarola A; Di Fiore A; Dainelli M; Grani G; Calvanese A
    Exp Clin Endocrinol Diabetes; 2010 Nov; 118(10):678-84. PubMed ID: 20496313
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnosis and treatment of Graves disease.
    Streetman DD; Khanderia U
    Ann Pharmacother; 2003; 37(7-8):1100-9. PubMed ID: 12841824
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oxidation products and antioxidant markers in plasma of patients with Graves' disease and toxic multinodular goiter: effect of methimazole treatment.
    Bednarek J; Wysocki H; Sowinski J
    Free Radic Res; 2004 Jun; 38(6):659-64. PubMed ID: 15346657
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antithyroid drug regimen for treating Graves' hyperthyroidism.
    Abraham P; Avenell A; McGeoch SC; Clark LF; Bevan JS
    Cochrane Database Syst Rev; 2010 Jan; 2010(1):CD003420. PubMed ID: 20091544
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Experience with carbimazole in the treatment of the hyperthyroidism of Graves' disease in Nigerian patients.
    Modebe O
    Afr J Med Med Sci; 1995 Dec; 24(4):347-51. PubMed ID: 8886149
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reassessment of antithyroid drug therapy of Graves' disease.
    Feldt-Rasmussen U; Glinoer D; Orgiazzi J
    Annu Rev Med; 1993; 44():323-34. PubMed ID: 7682804
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Treatment of hyperthyroidism with antithyroid drugs].
    Eber O
    Acta Med Austriaca; 1995; 22(5):83-90. PubMed ID: 8651042
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Management of recurrent hyperthyroidism in patients with Graves' disease treated by subtotal thyroidectomy.
    Sugino K; Mimura T; Ozaki O; Iwasaki H; Wada N; Matsumoto A; Ito K
    J Endocrinol Invest; 1995 Jun; 18(6):415-9. PubMed ID: 7594234
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of hyper- and hypothyroidism.
    McDougall IR
    J Clin Pharmacol; 1981; 21(8-9):365-84. PubMed ID: 6168663
    [No Abstract]   [Full Text] [Related]  

  • 36. Graves' disease and radioiodine therapy. Is success of ablation dependent on the choice of thyreostatic medication?
    Kobe C; Weber I; Eschner W; Sudbrock F; Schmidt M; Dietlein M; Schicha H
    Nuklearmedizin; 2008; 47(4):153-6. PubMed ID: 18690374
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Current problems in the treatment of Graves' disease in pregnancy and in lactation].
    Momotani N
    Nihon Rinsho; 2006 Dec; 64(12):2297-302. PubMed ID: 17154095
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outcome Prediction of Treatment of Graves' Hyperthyroidism with Antithyroid Drugs.
    Piantanida E; Lai A; Sassi L; Gallo D; Spreafico E; Tanda ML; Bartalena L
    Horm Metab Res; 2015 Sep; 47(10):767-72. PubMed ID: 26197855
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Thyrostatic treatment and its adverse effects].
    Dokupilová A; Payer J
    Vnitr Lek; 2013 Nov; 59(11):989-95. PubMed ID: 24279443
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnosis and management of hyperthyroidism from prenatal life to adolescence.
    Léger J; Carel JC
    Best Pract Res Clin Endocrinol Metab; 2018 Aug; 32(4):373-386. PubMed ID: 30086864
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.